We think Biogen's neurology, immunology, and focus on rare diseases support a narrow moat. Biogen's strategy has its roots in the 2003 merger of Biogen (Avonex for treating multiple sclerosis, or MS) ...

Biohaven has won Food and Drug Administration priority review for its application seeking approval of troriluzole for adults with spinocerebellar ataxia, a group of rare, genetic neurological ...

Cure Rare Disease (CRD) announced it has been awarded a $5.69 million grant from the California Institute for Regenerative ...

SOUTH SAN FRANCISCO, Calif. - Quince Therapeutics, Inc. (NASDAQ: QNCX), a biotech firm focusing on rare diseases with a current market capitalization of $67.76 million, has received a Notice of ...

(AP Photo/Mark Schiefelbein) WASHINGTON (AP) — Donald Trump in his first week back in the White House has offered an early preview to his second-term foreign policy approach: Talk loudly and wield a ...

If euro area inflation indeed approaches its target, as hoped, some changes in the ECB’s approach will be needed. Like a car driver nearing the end of a curve who looks further ahead and returns ...

Garmin has announced the Approach S44 and S50 golf watches, plus a CT1 club attachment tracker and an Approach G20 Solar handheld tracker. Earlier this month I said the Instinct 3 completed Garmin ...

AGNC Investment Corp. AGNC is slated to report fourth-quarter 2024 earnings on Jan. 27, after market close. AGNC’s third-quarter results reflected an improvement in average asset yield on its ...